The present disclosure relates in general to angioplasty, and in particular to methods and apparatus for use in the treatment of blood vessel occlusion, including chronic total occlusion.
The treatment of blood vessel occlusions generally involves the use of percutaneous angioplastic techniques to advance a micro guiding catheter to the location of the occlusion, and to penetrate the occlusion with a wire or dedicated occlusion penetrating device in order to create a micro channel into which the operator can later introduce other percutaneous devices such as angioplasty balloons, and to fully restore blood flow. The mechanism behind occlusion crossing is based on a constant advancement of the wire or dedicated occlusion penetrating device, which allows it to be diverted into the natural micro-channels located within the occlusion until full crossing is achieved.
Blood vessel occlusions may be acute or chronic, and chronic occlusions, often referred to as Chronic Total Occlusion (“CTO”), are typically fibrotic and often also calcified. CTOs may also be longer than acute occlusions. Accordingly, relatively high axial forces may be required in order to penetrate and advance a wire or dedicated penetrating device through a CTO.
There is an obvious mechanical limitation to the amount of forward axial force that can be transmitted through a wire because a wire will easily buckle without radial support. Micro guiding catheters (which typically comprise a tight tube having an inner diameter that is only marginally greater than the diameter of the wire, and which are stiff but flexible enough to allow the operator to push them trough the vasculature of the patient to the CTO site) are accordingly commonly used in known CTO treatment techniques.
However, although the use of a micro guiding catheter improves the amount of available axial force, it does not provide the operator with the full potential of force delivery. This derives from the action-reaction physical law, as pushing a wire constrained within a tube against an obstacle will result in a force acting at the opposite direction from the obstacle back to the wire and to the constraining tube. If the constraining tube is dislodged from the treatment site, the wire in the vicinity of the dislodgement may be exposed, and thereby the wire may lose its ability to deliver axial force or buckle.
In order to keep the wire fully protected throughout the procedure, the operator must accordingly pay constant attention to the catheter's tip position, keeping it as close as possible to the occlusion. This is not, however, always feasible because the tortuous path the catheter may be required to follow to arrive at the treatment site can cause a loss of force and/or control at each of the bends the catheter makes. Additionally, in using a typical micro guiding catheter, the operator needs to be careful not to exceed the maximum allowed axial force that could result in buckling of the catheter itself.
Current state of the art micro guiding catheters thus provide a partial solution for wire buckling and thereby increase slightly the amount of force the operator can apply, but they do not contemplate catheter tip securement, and therefore do not provide the operator with the full potential of force transmutation through the wire. Other state of the art techniques have accordingly been developed to facilitate securement of the micro catheter at the occlusion treatment site.
These methods involve the use of an angioplasty balloon that, upon inflation, pushes the distal end of the micro guiding catheter shaft against the blood vessel wall. The shaft is therefore pressed between the inflated balloon and the vessel wall, and this keeps the distal end of the catheter relatively secured. However, the use of an angioplasty balloon to secure the distal end of a micro catheter has several disadvantages as well. Most important among these is the safety issue of pushing the shaft into a vessel wall, which could potentially cause serious injury. A further drawback is the resulting inability for the operator to reposition the catheter tip during the procedure since the catheter is virtually locked against the vessel wall. A variant of this method involves a coaxial set up that allows free movement of the wire; however, the risk of vessel injury due to balloon force applied is still present.
This summary is not an extensive overview intended to delineate the scope of the subject matter that is described and claimed herein. The summary presents aspects of the subject matter in a simplified form to provide a basic understanding thereof, as a prelude to the detailed description that is presented below.
Provided herein is a method for the treatment of blood vessel occlusions, comprising the localized anchoring of a catheter during the procedure by temporarily adhering its tip to the occlusion treatment site using a vacuum. Also provided is a catheter with a vacuum anchoring tip controlled by an externally generated vacuum, a catheter with a vacuum anchoring tip controlled by a self-generated vacuum, and a catheter with a vacuum anchoring tip in which the vacuum s controlled by an electronic signal. The localized anchoring method utilizes a vacuum to secure the tip of the catheter in place while allowing a free passage for the wire or dedicated occlusion penetrating device, and therby frees the operator from constantly monitoring the tip position and pushing the catheter to support the advancement of the wire.
For a fuller understanding of the nature and advantages of the disclosed subject matter, as well as the preferred mode of use thereof, reference should be made to the following detailed description, read in conjunction with the accompanying drawings. In the drawings, like reference numerals designate like or similar steps or components.
With reference to
The tip 100 is preferably formed from a single piece of a flexible material that can be manufactured by injection molding, by two piece mold assembly methods, or by machining. In preferred embodiments, the outer surface geometry of tip 100 has seven distinct areas, as follows: sealing ring 1, sealing ring recess 2, contact chamber wall 3, vacuum chamber wall 4, chambers divider recess 5, vacuum chamber recess 6, and tail wall 7. The inner surface geometry of tip 100 also has, in preferred embodiments, seven distinct areas, as follows: secondary sealing ring 8, chambers divider septum 9, guiding cone 10, tail 11, vacuum chamber 12, chambers divider lumen 14, and contact chamber 14.
The sealing ring 1 serves as the primary contact zone for adhering the tip to the occlusion site to create an initial seal and thus to allow vacuum to be built up in the tip 100. Associated sealing ring recess 2 facilitates the sealing of the sealing ring 1 by enhancing the flexibility thereof vis-à-vis the occlusion site.
As vacuum is built up within tip 100, contact chamber 14 becomes the main interface between the tip 100 and the target surface of the occlusion site. Secondary sealing ring 8 is optional, and in embodiments that include it enhances further sealing ability of the contact chamber 14 by providing additional reinforcement.
As is best seen in
With reference now to
The chambers divider lumen 13 connects the vacuum chamber 12 and contact chamber 14, and is suitably constructed and dimensioned to permit the free passage therethrough of a wire or dedicated occlusion penetrating device during use (see
The chambers divider recess 5 facilitates flexibility between the vacuum chamber 12 and contact chamber 14, thereby providing contact chamber 14 with additional degrees of freedom to bend and thus to better fit to the topography of the target surface without breaking vacuum, and also to minimize the effect of bending of the catheter shaft 16.
The vacuum chamber recess 6 provides a secondary flexibility zone, but also guides the tip 100 into its delivery sleeve prior to the procedure (see
The tail 11 provides an interface between the flexible tip 100 and the catheter shaft 16, and it's the thickness and shape of the tail wall 7 are optimized for various known bonding or fusing techniques, including lamination, in which case tail wall 7 could be placed in between the layers that comprise a conventional catheter shaft 16.
Guiding cone 10 is dimensioned to guide the wire or dedicated occlusion penetrating device through the center of the tip 100, and reduces the risk of damage to the inner structure of tip 100 in embodiments where a stiff wire or dedicated occlusion penetrating device is being used (see
Referring now to
In addition, as best seen in
By way of comparison,
The difference in force reaction is converted through the isolating point to different angled force vector (d1, d2), that causes internal deformation of the chambers which do not affect the tension force (t1, t2). @M1: t1+d1=T1; @M2: t2+d2=T2
Referring now to
In preferred embodiments, the frame 20 comprises radial spring 21 and two or more pairs of asymmetrical connecting struts 22 in communication with embedded actuation wires or struts 23 within the shaft 16. The embedded actuation wires or struts 23 within the shaft 16 are preferably located in dedicated lumens 24. In other embodiments, the frame may comprise an uneven number of connecting struts 22 and actuation wires or struts 23.
The present description includes the best presently contemplated mode of carrying out the subject matter disclosed and claimed herein. The description is made for the purpose of illustrating the general principles of the subject matter and not be taken in a limiting sense; the subject matter can find utility in a variety of implementations without departing from the scope of the disclosure made, as will be apparent to those of skill in the art from an understanding of the principles that underlie the subject matter.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/CA11/01056 | 9/20/2011 | WO | 00 | 7/23/2013 |
Number | Date | Country | |
---|---|---|---|
61384692 | Sep 2010 | US |